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it may represent a pore-forming subunit of a brain and fl-cell 
Abstract The ATP-sensitive K-channel plays a central role in KAT P channel [5]. 
insulin release from pancreatic/3-cells. We report here the don- In this study, we report the cloning and genomic structure 
ing of the gene (KCNJ6) encoding a putative subunit of a human of the human BIR1 gene, identification of its chromosomal 
ATP-sensitive K-channel expressed in brain and /]-cells, and 
characterisation of its exon-intron structure. Screening of a location and determination of the frequency of polymorphisms 
somatic cell mapping panel and fluorescent in situ hybridization in this gene. 
place the gene on chromosome 21 (21q22.1-22.2). Analysis of 
single-stranded conformational polymorphisms revealed the pres- 2. Materials and methods 
ence of two silent polymorphisms (Pro-149: CCG-CCA and Asp- 
328: GAC-GAT_.) with similar frequencies in normal and non- 2.1. Isolation of the human BIR1 genomic DNA 
insulin-dependent diabetic patients. The human BIR1 gene was isolated from a human genomic library 
(Clonetech and ATCC) using the full-length rat BIR1 cDNA [5] as a 
Key words: ATP-sensitive K-channel; Pancreatic fl-cell; probe. High stringency screening of 106 plaques was carried out using 
50% formamide, 5 × SSPE, 5 × Denhardt's solution, 0.5% SDS, and 100 
Diabetes; BIR1; KCNJ6 /lg/ml denatured salmon sperm DNA at 37°C. The filters were washed 
with 0.2 × SSC at room temperature. Clones were purified by screening 
at reduced ensity, DNA prepared from positively-hybridizing clones, 
and the exons identified by restriction enzyme mapping and Southern 
1. Introduction blot analysis. Appropriate restriction fragments were then subcloned 
into pBluescript SK , and nucleotide sequences determined. The posi- 
tions ofexon intron boundaries were determined by comparison of the 
ATP-sensitive K-channels (Kmp channels) are closed by an human genomic and rat cDNA sequences. 
increase in the intracellular ATP concentration of the cell and 
thereby provide a means of linking cellular metabolism to the 2.2. Chromosomal localisation 
PCR amplification. Two PCR primers (sense: 5'-GGCCGAGTTA- 
electrical excitability of the plasma membrane [1]. Their physi- GCCAGCA-Y; antisense: 5'-TGCCCAGCTAGGGCAC-Y) were de- 
ological function is best understood in the pancreatic fl-cell signed to amplify a 178 bp fragment from the 3' end of the human BIR1 
where they play a key role in the regulation of insulin secretion coding sequence and PCR carried out with a Perkin-Elmer Cetus 
in response to nutrients [2]. Closure of KATp channels, as a thermocycler (GeneAmp PCR System 9600). The PCR conditions con- 
result of metabolically generated ATE produces membrane sisted of 35 cycles of 94°C for 20 s, 63°C for 40 s and 72°C for 20 s. 
Each 25/tl PCR reaction contained 25 ng of DNA template, 0.2/zmol 
depolarisation. This leads to activation of voltage-sensitive of each PCR primer, 400/zM dNTPs and 1 unit of Amplitaq. 
Ca 2÷ channels, Ca 2+ influx and ultimately insulin release. Kmp Fluorescence in situ hybridisation. Total phage DNA was labelled 
channels are also believed to also play important roles in the with biotin-11-dUP by nick translation [6]. The hybridisation mixture 
response to cardiac and cerebral ischaemia [1]. contained 200 ng labelled probe DNA and 2.5 pg unlabelled human 
Cot-1 DNA, previously denatured and annealed at 37°C for 15 rain 
A complementary DNA encoding a KAT P channel subunit prior to hybridization. Hybridization to normal human male meta- 
(KAvp 1) was first cloned from rat cardiac muscle [3]. Northern phase chromosomes was carried out at 42°C overnight. After stringent 
blot analysis showed that although this mRNA is expressed in washes, the site of hybridization was detected with successive layers of 
heart and brain it is not found in pancreatic fl-cells. Subse- fluorescein-conjugated avidin (5 ¢tg/ml; Vector Labs) and biotinylated 
quently, a related channel (BIR1) was cloned from rat insuli- with anti-avidin (5 ,ug/ml; Vector Labs). Slides were mounted in Vec- 
tashield (Vector Labs) containing antifade, 1 ,ug/ml propidium iodide 
noma cells [5]. This subunit shows 72% homology with KATp-1 and 1 ¢tg/ml 4',6'-diamidinophenylindole (DAPI) to allow concurrent 
and is expressed in insulinoma cells and in brain. Both of these G-banded analysis under UV light. Results were analysed and images 
channel subunits possess only two transmembrane s gments, captured using a Bio-Rad MRC 600 confocal aser scanning micro- 
linked by a highly conserved P-region which is believed to form scope. 
the lining of the pore itself. This molecular architecture, to- 2.3. PCR-SSCP analysis' 
gether with the electrophysiological properties, places KATP-I Genomic DNA was obtained from white peripheral blood cells from 
and BIR1 in the inward rectifier family of K-channels [8]. A1- normal humans and from 96 patients with non-insulin-dependent dia-
though BIR1 lacks many of the properties of the native fl-cell betes mellitus (NIDDM) chosen from the UK Prospective Diabetes 
KAVp channel, the high sequence homology to KAVp-~ suggests Study [10]. PCR primers (Table 1) were chosen to amplify each of the 
exons and the adjacent flanking regions containing the exon intron 
junctions. In order to maximize the possibility of detecting enetic 
*Corresponding author. Fax: (44) (1865) 27-2469. variations by SSCP, the amplified DNA fragments were designed to 
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Table 1 
Sequence of PCR primer pairs used to amplify the coding regions of the human BIR1 gene 
Segment no. Sense upstream primer Antisense downstream primer Fragment size 
1 AAAGAGCCAGCCTTTCATTC CGTCTTTCCTCACGTACCTC 207 
2 CCTGCCAAGACACATCAGCC CTATGTGGTCCATGTCTCCC 257 
3 ATGATC TGGTGGTTGATCGC C CCAC CATGAATGCATTGAC 236 
4 ATCCAATCTGTGTTGGGGTC TGAACTCCCCCTCCGAGGTC 244 
5 ACATTGTGGAGGCTTCCATC CCAGTTCCTCTTTGGGCAGC 216 
6 GTCACCGCTGATCATTAGCC ATCCCAGGATAGAACACATC 149 
7 CATGGAAAGCCCACACTTAC GACCAACTCAGGGGCAGCTC 258 
8 ATCCCTTAGTGCCAAAGAGC AAGAGAAGGGTTTGCCCAGC 211 
All primer sequences are written in the 5'-to-3' orientation. 
overlap with one another and to be smaller than 300 bp. SSCP was amino acids around the two transmembrane and the pore re- 
performed using the method of Kishimoto et al. [9]. Briefly, 1/tl of the gions are completely conserved across these species (Fig. 1). 
primer-pair (10 pmol each) was labelled by phosphorylation with pol- 
ynucleokinase and [z-nP]ATP. 0.5 pmol of labelled primer was used for 
3.2. Chromosomal localisation each PCR. The amplification conditions comprised an initial denatura- 
tion at 94°C for 5 min, followed by 35 cycles at 94°C for 1 rain; 50°C Screening of the N IGMS human/rodent somatic cell map- 
(segments 1, 5, 6) or 55°C (segments 2, 3, 4, 7 and 8) for 1 min; 72°C ping panel no. 2 amplified a single band of the predicted size 
for 1 min, and finally 72°C for 5 rain. The PCR products were loaded (178 bp) from human genomic DNA and the hybrid containing 
onto a 5% polyacrylamide gel, with or without 10% glycerol, and chromosome 21, but not from any other hybrids or from rodent 
subjected to electrophoresis at room temperature ata constant power 
of 40 W. After electrophoresis, the gel was dried and exposed to X-ray genomic DNA (Fig. 2A). The identity of this product was 
film without an intensifying screen for 12 24 h. To prepare single- confirmed by a Taql restriction site. Thus the BIRI gene re- 
stranded templates for DNA sequencing, a second PCR was performed sides on chromosome 21. A more detailed localisation was 
(25 cycles) with 2 gtl of the first PCR product as a template and 100 pmol carried out using fluorescence in situ hybridization using the 
of only one of the primers. The single-stranded products of the second clone BIR1 no. 10 as a probe. Approximately 20 metaphases PCR were purified by NucleiClean (Sigma) and sequenced with a 
32p-labelled primer. Data were analysed using zLanalysis using the were analysed at the 550 band level. As shown in Fig. 2B, the 
program Minitab. results confirm the assignment of the BIR1 gene to chromo- 
some 21, placing it at the interface between bands q22.1 and 
3. Results q22.2 (21q22.1-22.2). 
3.1. Isolation and characterization of the human BIR1 gene 3.3. Identification of genetic variations detected by SSCP 
Four clones containing the human BIR 1 gene were identified Eleven normal individuals were screened for polymorphisms 
by high stringency hybridization. Restriction mapping of these in the BIR 1 gene by single-stranded conformational polymor- 
clones demosntrated that three (BIRI nos. 6, 8 and 23) were phism analysis (SSCP)under two different conditions (presence 
probably identical and one (BIR1 no. 10) was distinct. More or absence of 10% glycerol). As the entire protein coding region 
detailed mapping was performed on clones nos. 8 and 10. Fig. of BIR1 is contained within the two exons identified, only these 
1 shows the nucleotide sequences of the coding regions and the exons were studied. Two polymorphic regions were detected 
adjacent introns obtained from these two clones. BIR1 no. 10 (Fig. 3), one in each exon. Direct sequence nucleotide analysis 
contained the sequences encoding a putative initiation methion- (Fig. 3B) demonstrated that these are silent mutations: Pro- 149 
ine, the pore region and both of the flanking transmembrane CCG-CCA and Asp-328 GAC-GAT.  We also identified the 
region but did not contain the intracellular C-terminal domain, same polymorphisms in 96 N IDDM patients at a similar fre- 
The coding region of BIR1 no. 8 was contiguous with that of quency to that found in normals (Pro-149, P = 0.30; Asp-328, 
BIR1 no. 10 and contained in addition the C-terminal region P = 0.60; normal vs. diabetic subjects). The allelic frequency 
and the 3' untranslated region. There was no sequence overlap was CCG = 0.77 and CCA = 0.23 in the case of Pro-149, and 
between the introns of BIRI no. 8 and 10, indicating that the GAC = 0.34 and CAT -- 0.66 in the case of Asp-328, including 
distance between the two exons must be more than 10 kilo- both normal and diabetic individuals. There was no linkage 
bases. Although we obtained the entire coding region of the disequilibrium between these polymorphisms (P = 0.86). 
human BIR1 channel gene we were unable to isolate the 5' 
untranslated region from the genomic library, suggesting that 4. Discussion 
there may be reduced homology between the 5' untranslated 
regions of the rat and human genes. Comparison of amino acid The predicted amino acid sequence for the rat and human 
sequences of the rat and human BIR1 channels within the BIR1 channel are highly homologous with 402 out of 407 resi- 
coding region reveals that only 5 out of 407 residues (1.2%) are dues (98.8%) being identical. There are 121 differences at the 
different (all lying within BIR1 no. 10, Fig. 1B), and that the nucleotide level within the coding region (90.9% identity). The 
- - )  
Fig. 1. (A,B) Nucleotide and predicted amino acid sequence for two exons (A,B) of the human BIR1 gene which span the coding region and the 
adjacent exons: Upper case letters = exon, lower case, intron. (A) BIR1 no. 8. *** = Putative initiation codon; arrow = polymorphic nucleotide. 
(B) BIR1 no. 10. The corresponding rat amino acid sequence is included below for comparison: dots represent common residues. * = termination 
codon; arrow = polymorphic nucleotide. 
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t tcaccagcccatacaaagtgtgccgt tccat tg tcc tcaaagagccagcct t tcat  tcagtgt t  t c t t t tc t  t t tct  
*** 14 
c c aaa  c c ac cag  / CTAACGTCC TGGAGGGCGACTCCATGGATCAGGACGTCGAAAGCCCAGTGGCCATTCACCAGCCA 
N V L E G D S M D Q D V E $ P V A I H Q P 
4O 
AAGTTGCCTAAGCAGGCCAGGGATGACC TGC CAAGACACATCAGCCGAGATCGGACCAAAAGGAAAATCCAGAGGTAC 
K L P K Q A R D D L P R H I S R D R T K R K I Q R Y 
41 66 
GTGAGGAAAGACGGAAAGTGCAATGTTCATCACGGCAACGTGAGGGAGACCTATCGCTACCTGACCGATATCTTCACC 
V R K D G K C N V H H G N V R E T Y R Y L T D I F T 
67 92 
AC ATTAGTGGACC TGAAGTGGAGATTCAACC TATTGATTTTTGTCATGGTTTACACAGTGACCTGGCTCTTTTTTGGA 
T L V D L K W R F N L L I F V M V Y T V T W L F F G 
93 118 
ATGATC TGGTGGTTGATCGCATACATACGGGGAGACATGGACCACATAGAGGACCCCTCCTGGACTCCTTGTGTTACC 
M I W W L I A Y I R G D M D H I E D S P W T P C V T 
119 144 
AAC C TCAACGGGTTCGTC TCTGCTTTTTTATTCTCAATAGAGACAGAAACCACCA~TTATGGCTACCGGGTCATC 
N L N G F V S A F L F S I E T E T T I G Y G Y R V I 
145 1 170 
ACAGATAAATGC CCGGAGGGAATTATTC TTCTCTTAATCCAATCTGTGTTGGGGTCCATTGTCAATGCATTCATGGTG 
T D K C P E G I I L L L I Q S V L G S I V N A F M V 
171 196 
GGATGCATGTTTGTAAAAATC TCTCAACC CAAGAAGAGGGCAGAGAC CCTGGTCTTTTCCACCCATGCAGTGATCTCC 
G C M F V K I S Q P K K R A E T L V F S T H A V I S 
197 222 
ATGCGGGATGGGAAACTGTGCCTGATGTTCCGGGTAGGGGAC CTTAGGAATTCCCACATTGTGGAGGC TTCCATCAGA 
M R D G K L C L M F R V G D L R N S H I V E A S I R 
223 248 
GCCAAGTTGATCAAATCCAAACAGACC TCGGAGGGC4]AGTTCATC C GTTGAACCAGACGGATATCAACGTAGGGTAT 
A K L I K $ K Q T $ E G E F I P L N Q T D I N V G Y 
249 274 
TACAC~ATGACCGTCTGTTTC~TGTCACCGCTGATCATTAGCCATGAAATTAACCAACAGAGTCCTTTCTGG 
Y T G D D R L F L V S P L I I S H E I N Q Q S P F W 
275 299 
GAGATC TCCAAAGCCCAGCTGCCCAAAGAGGAACTGGAAATTGTGGTCATC CTAGAAGGAATGGTGGAAGCCACAG / g
E I S K A Q L P K E E L E I V V I L E G M V E A T 
taagatgtgt  tc ta tcc tgggatggctgtgggatagatgctcat  t t taaactggacctgatgt tc t ta tc ta t tacaa  
gatc tagaatactgaacctcactcaatat tgacaacatcccct t  
300 
. .ggctc tc tg tgactcc t tggccatggaaagcccacact tacatatgctaaagcctccat tc t tc tc tc tgcag/~ 
G 
301 326 
A~ACATGCC~GC~G~GC~CTACATCACCAG~AGATCC~ACC~TTCACACC~C~ACCC~ 
M T C Q A R S S Y I T S E I L W G Y R F T P V L T L  
. . . . . . . . .  v . . . . . . . . . . . .  
327 ~ 352 
GA~ACGGG~CTACG~GTTGACTAC~CAGC~CCA~AGACCTA~AGACCAGCACCCCATCCC~AG~CCAAA 
E D G F Y E V D Y N S F H E T Y E T S T P S L S A K  
. . . . . . . . . . . . . . .  H . . . . . . . . . .  
352 378 
GAGCTGGCCGAGTTAGCCAGCAGC43CAGAGC~CCCC~AGTTGGTC~TA~CAGCAAACTC~CC~CA~CAG~ 
E L A E L A S R A E L P L S W S V S S K L N Q H A E  
. . . . . .  N . . . . . . . . . . . . . . . . . . .  
379 404 
CTGGAGAC~GA~GAAAAG~CCTCG~GAGCAAACAGAAAGAAATGG~A~TGGCAAACCTGGAG~ 
L E T E E E E K N L E E Q T E R N G D V A N L E N E  
. . . . . . . . .  P L . . . . . . . . . . . . .  
405 407 
~CAAAGTTTAG~CCCTAGC~CAAACCCTTCTC~CTCCCCCC~CAC~TTTCCTTGTCTCTCATTCTCTT 
S K V *  
TCTTTTT 8 
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Fig. 2. (A) PCR amplification of human BIR1 from chromosome 21. L = DNA size markers; 1 = hybrid containing chromosome 21; 2 = human 
genomic DNA; 3 -- hamster/mouse g nomic DNA; 4 -- no DNA control. The expected 178 bp band is indicated by the arrow. (B) Fluorescence in
situ hybridization of BIR1 to normal human metaphase. The fluorescent signal appears green and the propidium iodide stained chromosomes appear 
red. (C) Ideogram of chromosome 21 showing location of BIR1. 
coding region of the human BIR1 gene is contained within important role in the regulation of insulin secretion from the 
2 exons. However, we cannot exclude the possibility that fur- pancreatic fl-cell, and functional mutations in this channel may 
ther exons exist, 5' of the putative initiator methionine. Indeed, be expected to lead to defects in insulin secretion. If BIR1 
potential coding sequences 5' of the equivalent methionine in indeed comprises the pore-forming subunit of the fl-cell KAT P 
the rat BIR1 gene have been identified (unpublished observa- channel, with other subunits conferring additional functional 
tions): it is not known if these additional codons are actually properties, then mutations in these ancillary subunits may be 
translated, but expression studies using the form of the rat associated with N IDDM.  
cDNA equivalent to the human sequence described here did Our data provide an essential basis for subsequent screening 
result in functional channel activity [5]. We were not successful of diabetic patients to determine if mutations in BIR1 are in- 
in obtaining the 5' untranslated region of the human BIR 1 gene volved in the aetiology of maturity-onset diabetes of the young 
using a rat probe presumably due to significant sequence vari- or non-insulin-dependent diabetes. In addition, mutations of 
ability between the human and rat genes in this region, the KATp channel might be involved in other pathological con- 
Our results show that the human BIR1 gene is located on ditions. For instance, BIR1 is expressed in brain, and KAT P 
chromosome 21, towards the distal end of the long arm: we are channels are believed to be important in the cerebral response 
not aware of any human disease which is associated with this to ischaemia nd hyperglycaemia [1,4,7]. It may therefore be 
region. We found two common polymorphisms in the human appropriate to determine whether individuals who have had a 
BIR 1 gene. Both of these are single base substitutions, and do stroke possess mutations in BIR1. 
not result in coding sequence alterations. Although we have not 
yet found linkage between the BIR1 gene and a human disease, Acknowledgements: We hank the Wellcome Trust, the British Diabetic 
linkage may yet be found in the 5', 3' or gene control sequences Association, The Medical Research Council of the UK, the National 
which we have not yet examined. The KAy P channel plays an Institute of Health, the Alan and Babette Sainsbury Trust, the Yama- 
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Fig. 3. (A,B) SSCP analysis showing mobility shifts of single-stranded DNA fragments due to single base substitutions in Pro-149 (A) and Asp-328 
(B). Samples were amplified by PCR with the corresponding primers (segment 3 and 7) and subjected to electrophoresis in neutral polyacrylamide 
without glycerol at room temperature. Patients marked AA are homozygous for the major variant of the polymorphism, BB are homozygous for 
the minor variant and AB are hetereozygotes. (C) Sequencing of PCR fragments in individuals homozygous for variant A (left) and B (right) of 
Pro-149. The mutation is silent: A = CCG, B = CCA. D. Sequencing of PCR fragments in individuals homozygous for variant A (left) and B (right) 
of Asp-328. The mutation is silent: A =--GAT, B =-GAC. 
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